References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H. Brunton et al., Mol. Cell. Biol., Oct 2011; 31: 4022 - 4035 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | P. Hubel et al., Nature Immunology, 2019, 20: 493–502, https://doi.org/10.1038/s41590-019-0323-3. | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Tsolou et al., Cancer Biol. Med., 2017, 14 (3): 293-301, doi: 10.20892/j.issn.2095-3941.2017.0049 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | |
||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S.-E. Cheng et al., PLoS ONE, 2013, 8(1): e54125. doi:10.1371/journal.pone.0054125 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. .I Koukourakis et al., Laboratory Investigation, 2017, 97: 1321-1331, doi:10.1038/labinvest.2017.79 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Am J Physiol Lung Cell Mol Physiol, Sep 2012; 303: L401 - L412 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | |
||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Z. Zeng et al., DNA Repair, October 2017, 58: 52-61 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. V. Karagounis et al., British Journal of Cancer, 2016, 115: 312-321; doi: 10.1038/bjc.2016.202 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P.-S. Hsu et al., Int. J. Mol. Sci., 2015, 16: 27640-27658; doi:10.3390/ijms161126045 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M.-J. Kim et al., Cancer Letters, 2013, 339: 15–24, doi.org/10.1016/j.canlet.2013.07.027 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. L. Rulten et al., Nucleic Acids Res., Jan 2014; 42: 307 - 314 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | I-T. Lee et al., J. of Nutritional Biochemistry, 2013, 24: 124–136, doi.org/10.1016/j.jnutbio.2012.03.009 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | W. Kim et al., J. Biol. Chem., 287 (8): 5278–5289, DOI 10.1074/jbc.M111.281709 | Link | |
hBCSCs |
Human breast cancer stem cells (from xenografts of human breast cancers) | Human | respiratory system | stem cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | W.-W. Chang et al., Breast Cancer Res., 2013, 15: R39, doi:10.1186/bcr3423 | Link | ||
HLF |
Human lung fibroblasts | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Deng et al., J. Cell. Biochem., 2017, 118: 4012-4019, DOI 10.1002/jcb.26057 | |||
HPAEpiC |
Human pulmonary alveolar epithelial cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Front. Pharmacol. 2016, 7:80; doi: 10.3389/fphar.2016.00080 | Link | ||
hPAEpiC |
Human pulmonary alveolar epithelial cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin, PLoS ONE, 2015, 10(3): e0118473; doi:10.1371/journal.pone.0118473 | Link | ||
HPAEpiC |
Human pulmonary alveolar epithelial cells (type II) | Human | respiratory system | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | I-T. Lee et al., J. of Nutritional Biochemistry, 2013, 24: 124–136, doi.org/10.1016/j.jnutbio.2012.03.009 | |||
hPASMC |
Human pulmonary artery smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Cell Physiol., July 2017, 313: C380 -C391; doi:10.1152/ajpcell.00061.2017 | |||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-W. Lee et al., Mol. Pharmacol., May 2008; 73: 1454 - 1464 | |||
hTSMC |
Human primary tracheal smooth muscle cells | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-C. Lin et al., Am. J. Physiol. Lung Cell Mol. Physiol., 2015, 309: L211-L225; doi:10.1152/ajplung.00232.2014 | Link |









